Grace Therapeutics (GRCE) Return on Assets [ROA] (2020 - 2026)
Grace Therapeutics (GRCE) recorded Return on Assets [ROA] of -34.65% in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 20.10 percentage points from -14.55% a year earlier and down 23.11 percentage points from the prior quarter.
Powered by 
Analysis
Grace Therapeutics (GRCE) Return on Assets [ROA] (2020 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Grace Therapeutics reported Return on Assets [ROA] of -11.24%, up 1.93 percentage points from FY2025.
- Annual Return on Assets [ROA] has increased for three straight fiscal years, with a five-year change of +34.89 percentage points (FY2021 to FY2026).
- Across earlier fiscal years, Return on Assets [ROA] came in at -13.17% in FY2025 (+3.69 pp), -16.86% in FY2024 (+23.98 pp), -40.85% in FY2023 (-30.57 pp) and -10.28% in FY2022 (+35.85 pp).
- The fiscal Q1 2027 figure is the lowest quarterly Return on Assets [ROA] since fiscal Q3 2024.
- On a year-over-year basis, Return on Assets [ROA] rose in seven of the last eight quarters, with an average year-over-year change of +8.77 percentage points.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 136.26 percentage points in fiscal Q2 2022, against a drop of 46.26 percentage points in fiscal Q1 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at -11.53% (Q4 2026), -8.85% (Q3 2026) and -11.47% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.14% |
| 10 | Grace Therapeutics | 34.02 Mn | -32.25 Mn | - | -34.65% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -34.65% |
| Mar 31, 2026 | -11.53% |
| Dec 31, 2025 | -8.85% |
| Sep 30, 2025 | -11.47% |
| Jun 30, 2025 | -14.55% |
| Mar 31, 2025 | -14.36% |
| Dec 31, 2024 | -21.13% |
| Sep 30, 2024 | -17.19% |
| Jun 30, 2024 | -16.01% |
| Mar 31, 2024 | -17.20% |
| Dec 31, 2023 | -50.23% |
| Sep 30, 2023 | -53.25% |
| Jun 30, 2023 | -55.11% |
| Mar 31, 2023 | -43.31% |
| Dec 31, 2022 | -14.51% |
| Sep 30, 2022 | -13.94% |
| Jun 30, 2022 | -8.85% |
| Mar 31, 2022 | -8.09% |
| Dec 31, 2021 | -7.02% |
| Sep 30, 2021 | -7.06% |
API Access
Grace Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();